Canada · Delayed Price · Currency is CAD Arch Biopartners Statistics
Total Valuation
TSXV:ARCH has a market cap or net worth of CAD 62.96 million. The enterprise value is 65.53 million.
| Market Cap | 62.96M |
| Enterprise Value | 65.53M |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.11M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.91% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 22.40% |
| Owned by Institutions (%) | n/a |
| Float | 51.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -743.27 |
| PB Ratio | -17.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.45 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -136.48% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 53.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.26% in the last 52 weeks. The beta is 1.37, so TSXV:ARCH's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -51.26% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.70 |
| Relative Strength Index (RSI) | 25.39 |
| Average Volume (20 Days) | 80,214 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, TSXV:ARCH had revenue of CAD -84,711 and -2.39 million in losses. Loss per share was -0.04.
| Revenue | -84,711 |
| Gross Profit | -820,918 |
| Operating Income | -1.97M |
| Pretax Income | -2.39M |
| Net Income | -2.39M |
| EBITDA | n/a |
| EBIT | -1.97M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 167,460 in cash and 2.67 million in debt, giving a net cash position of -2.50 million.
| Cash & Cash Equivalents | 167,460 |
| Total Debt | 2.67M |
| Net Cash | -2.50M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -3.66M |
| Book Value Per Share | -0.06 |
| Working Capital | -3.66M |
Cash Flow
| Operating Cash Flow | -1.80M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 2,327.25% |
| Pretax Margin | 2,817.75% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:ARCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.91% |
| Shareholder Yield | -0.91% |
| Earnings Yield | -3.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:ARCH has an Altman Z-Score of -198.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -198.27 |
| Piotroski F-Score | 2 |